Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 18, 2026, titled “Glenmark Pharmaceuticals Inc., USA Launches Vancomycin Hydrochloride for Injection USP, 500mg/vial and 1 g/vial”. |SUBJECT: Press Release
Form 2.1 |SUBJECT: Annual Impact Report
Form 1B (updated) |SUBJECT: Annual Disclosure
Form 1A |SUBJECT: Annual Disclosure
Form 1A, Form 1B and Form 2.1 |SUBJECT: Annual Disclosure
IRB Infrastructure Developers Limited has informed the Exchange regarding update received from IRB Infrastructure Trust for Commencement of Toll Collection – Ganga Expressway Project. |SUBJECT: Updates
Disclosure Under Regulation 51 |SUBJECT: Disclosure Under Regulation 51
ICICI Prudential Life Insurance Company Limited has informed the Exchange about disclosure under Regulation 30 of Listing Regulations. |SUBJECT: General Updates
IRB INFRASTRUCTURE TRUST has informed the Exchange Update regarding Ganga Expressway Project. |SUBJECT: Updates
Om Power Transmission Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates